The conference consists of talks given in Oxford, and online e-Presentations which replace conventional posters.

1.  Oxford-based, live-streamed talks

The focus of Oxford-based talks will be on clinical use, including practice and policy perspectives:

• Clinical trials - all phases
• Large cohorts
• Long-term data
• Experimental medicine in patients
• Psychotherapy techniques
• Summaries of mechanisms and preclinical science
• Health economics
• Risk mitigation
• Relapse prevention - psychological or pharmacological
• Prophylactic 'vaccination' against depression
• Novel compounds
• Barriers to development

All talks being delivered in Oxford will be live-streamed, recorded and made available to all registered delegates until 5th October 2020.  

2.  e-Presentations 

We are replacing conventional posters with online e-Presentations. These can be about any of the above topics.  Submission of preclinical studies are also encouraged.

• Cellular mechanisms
• Animal studies
• Healthy volunteer studies
• Smaller cohort studies and reports of clinic experience
• Case studies

How will the online e-Presentations work?
Authors can create presentations in any format: a conventional poster pdf, or a slide deck of up to 10 slides, or a video presentation of up to 7 minutes. These can be viewed by all registered delegates in the week before the conference from 6pm BST on 27th March, until six months after.  
Authors of e-Presentations may either be in-person delegates (ox-delegates) or may be online e-delegates.   Having a presentation accepted as an e-Presentation does not guarantee a place as an ox-delegate, but will be taken into consideration.

Each e-presentation will be accompanied by up to three online Webmeetings, each lasting 20 minutes in the week before the main talks - from 27th March to 5th April.   In these Webmeetings, the author will present their data in no more than 5 minutes, followed by 15 minutes discussion. Webmeetings will be scheduled depending on the timezones of e-delegates and authors.  Any registered delegate may join any Webmeeting to discuss the presentation with the author and others. Where authors are happy to do so, a recording of the Webmeeting will be lodged on the e-Presentation system and will be available to registered delegates until 5th October 2020. 

***Please note the draft programme  will be updated frequently. ***  

Speaker confirmations will be updated throughout December 2019.  Current confirmations include:

Elias Dakwar, Columbia, US - Alcohol and drug use disorders

Paul Glue, Otago, NZ - Oral ketamine in anxiety disorders

Sunjeev Kamboj, UCL, UK - Craving in heavy drinkers
Steve Levine, Actify, US - Switching between ketamine and esketamine

Celia Morgan, Exeter, UK - Alcohol relapse prevention
Gerald Sanacora, Yale, US - Translational studies

Robert Schoevers, Groningen, NL - Oral esketamine
Carlos Zarate, NIMH, US - Translational studies